Treatments

Cannabinoids can be a novel allied when it comes targeting breast cancer cells

Cancer

Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer. (2018)

Abstract

Breast cancer is the second leading cause of death among women. Although early diagnosis and development of new treatments have improved their prognosis, many patients present innate or acquired resistance to current therapies. New therapeutic approaches are therefore warranted for the management of this disease[…]

Author Information

Blasco-Benito S, Seijo-Vila M, Caro-Villalobos M, Tundidor I, Andradas C, García-Taboada E, Wade J, Smith S, Guzmán M, Pérez-Gómez E, Gordon M, Sánchez C.

Complutense University, Madrid, Spain; Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain. Electronic address: s.blasco@ucm.es. Complutense University, Madrid, Spain; Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain. Complutense University, Madrid, Spain. Aunt Zelda’s, CA, United States. Complutense University, Madrid, Spain; Instituto Ramón y Cajal de Investigación Sanitaria, CIBERNED and IUIN, Madrid, Spain. Complutense University, Madrid, Spain; Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain. Electronic address: cristina.sanchez@quim.ucm.es.

Cannabinoids: a new hope for breast cancer therapy? (2012)

Abstract

Breast cancer is a very common disease that affects approximately 1 in 10 women at some point in their lives. Importantly, breast cancer cannot be considered a single disease as it is characterized by distinct pathological and molecular subtypes that are treated with different therapies[…]

Author Information

Caffarel MM1, Andradas C, Pérez-Gómez E, Guzmán M, Sánchez C.

Dept. Biochemistry and Molecular Biology I, School of Biology, Complutense University-CIBERNED-IRYCIS, Madrid, Spain.

Hypothesis: cannabinoid therapy for the treatment of gliomas? (2004)

Abstract

Gliomas, in particular glioblastoma multiforme or grade IV astrocytoma, are the most frequent class of malignant primary brain tumours and one of the most aggressive forms of cancer. Current therapeutic strategies for the treatment of glioblastoma multiforme are usually ineffective or just palliative[…]

Author Information

Velasco G, Galve-Roperh I, Sánchez C, Blázquez C, Guzmán M.

Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University, Avenida Complutense, sn, 28040 Madrid, Spain.

Treatments
_